How to Cite
Abstract
Comparative study of vitamins supplements traded in Colombia and the ideal requirements in patients with chronic kidney disease in dialysis therapyObjective: to establish whether any of the supplements sold in Colombia to comply with international recommendations suggested for patients with chronic renal disease in dialysis therapy. Materials and methods: review of vitamins and concentrations of all supplements sold in Colombia, and have current registration in the INVIMA. Only were accepted those that in their content had least three B-complex vitamins. We do not practice chemical evaluation of pharmaceutical products. A literature review is made. Results: if was found that none of the B complex or multivitamin preparations containing the dose or water-soluble and fat-soluble vitamins internationally recommended for patients with chronic kidney disease. Conclusions: there are not in the Colombian some multivitamin market products suitable for administration to patients with chronic renal dialysis therapy. This study should encourage laboratories to produce drugs with ideal combinations for patients with chronic kidney disease.
Key words: Vitamins. Vitamins requirements. Chronic kidney disease.
References
2. Heinz J, Domrose U, Westphal S, Luley C, Neumann K H, Dierkes J. Washout of water soluble vitamins and of homocysteine during haemodialysis: effect of high flux and low flux dialyser membranes. NEPHROLOGY 2008;13:384-9.
3. Descombes E, Hank A B, Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 1993;43:1319-28.
4. Boeschoten E W, Schrijver J, Krediet R T, Schreurs W H P, Arisz L. Deficiencies of vitamins in CAPD patients: the effects of supplementation. Nephrol Dial Transplant 1988;2:187-93.
5. Blumberg A, Hanch A, Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1983;20:244-50.
6. Mydlik M, Derzsiova K, Valek A, Szabo T. Dandar V, Takac M. Vitamins and continuous ambulatory peritoneal dialysis (CAPD). Int Urol Nephrol 1985;17:281-6.
7. Jagadha V, Deck J H, Halliday W C, Smyth H S. Wernicke ́s encephalopathy in patients on peritoneal dialysis or hemodialysis. Ann Neurol 1987;21:78-84.
8. Ihara M, Ito T, Yanagihara C, Nishimura Y. Wernicke ́s encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg 1999;101:118-21.
9. Ueda K, Takada D, Mii A, Tsuzuku Y, Saito S K, Kaneko T, et al. Severe thiamine deficiency resulted in Wernicke’s encephalopathy in a chronic dialysis patient. Clin Exp Nephrol 2006;10:290-3.
10. Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001;38:941-7.
11. Restrepo Valencia C A, Cruz J. Efectividad y seguridad del acido nicotinico en el tratamiento de la hiperlipidemia asociada a hiperfosfatemia en pacientes con enfermedad renal crónica. Nefrología 2008;1:61-6.
12. Kamata K, Okubo M, Marumo F. Water soluble vitamins in patients with chronic renal failure and effects of B6 administration of immunological activity. Proc Clin Dial Transplant Forum 1979;9:194-6.
13. Leblanc M, Pichette V, Geadah D, Ouimet D. Folic acid and pyridoxal-5-phosphate losses during high-efficiency hemodialysis in patients without hidrosoluble vitamin supplementation. J Ren Nutr 2000;10:196-210.